Prostate Cancer Trial, Recruiting NCT07626151 Sponsor: Nazmy Edward Seif Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT07626151
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are male and scheduled to have their prostate removed using a robot-assisted surgical procedure
  • People with a general health rating of ASA I, II, or III (a scale used by anaesthetists to classify overall fitness for surgery, ranging from very healthy to having severe ongoing health conditions)

Who may not be able to join:

  • People with an ASA health rating higher than III, meaning those with very severe or life-threatening health conditions
  • People with a BMI (a measure of body weight relative to height) above 40
  • People with severely reduced kidney function (where the kidneys are working at a very low level, but not yet in complete failure)
  • People who have previously had surgery on their kidneys
  • People with serious heart failure that significantly limits daily activity or causes symptoms at rest (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ashgan R Aly, M.D., Kasr Al-Ainy Hospital, Faculty of Medicine, Cairo University

Phone: +20 111 8370641

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nazmy Edward Seif
Registry
ClinicalTrials.gov
Start date
5 June 2026
Est. completion
1 December 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Serum Lactate level difference

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov